Eloxx Pharmaceuticals, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q1 2019 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Eloxx Pharmaceuticals, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q1 2019 to Q1 2023.
- Eloxx Pharmaceuticals, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2023 was $430K, a 44.8% increase year-over-year.
- Eloxx Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $1.37M, a 87.5% increase from 2021.
- Eloxx Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $728K, a 12.1% decline from 2020.
- Eloxx Pharmaceuticals, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $828K, a 16% decline from 2019.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)